Clobazam Tablet
Product Images NDC 0832-0581

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 0832-0581). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Clobazam 01)

Chemical structure of Clobazam, showing its molecular arrangement with a chlorinated benzene ring, nitrogen atoms, and ketone functional groups.*

FDA Label Image

Figure 1 (Clobazam 02)

Bar graph depicting the percentage reduction in weekly drop seizure rate across four groups: Placebo, Low, Medium, and High. The Placebo group shows a reduction of approximately 12.1%, Low about 41.2%, Medium about 49.4%, and High about 68.3%. Statistical significance is indicated for Low (p < 0.05) and Medium and High groups (p < 0.01).*

FDA Label Image

Figure 2 (Clobazam 03)

A bar chart showing the proportion of patients (%) achieving various ranges of reduction in weekly drop seizure frequency from baseline. The chart compares placebo with Clobazam low, medium, and high dose groups across reduction categories from 'Worse' to '80 to 100%'. Legend indicates groups with corresponding bar shading.*

FDA Label Image

Principal Display Panel (10 mg Tablet Bottle Label)

Label for Clobazam Tablets 10 mg oral tablets by Upsher-Smith Laboratories, LLC. The label states 100 tablets per container, includes storage instructions (20° to 25°C), and advises dispensing the Medication Guide to patients. Manufactured in New Zealand. The label features an NDC 0832-0580-11 and includes patient safety warnings to keep out of reach of children.*

FDA Label Image

Principal Display Panel (20 mg Tablet Bottle Label)

Clobazam 20 mg tablets label from Upsher-Smith Laboratories, LLC. The label states the dosage strength as 20 mg and indicates a package of 100 tablets. It includes storage instructions at 20° to 25°C and dispensing instructions emphasizing a child-resistant container. The label displays the National Drug Code (NDC) 0832-0581-11 and notes the product is Rx only, made in New Zealand.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.